// App-Quantinova.ai

3243 : Higher Baseline Hemoglobin and Splenectomy Are Risk Factors for Venous Thromboembolism in Adults with Sickle Cell Variant Genotypes

Researchers

Presenter

  • Michael B. Streiff

Principal Investigators

  • Julie Nelson

  • Sophie Lanzkron

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Acute chest syndrome

  • Sickle cell anemia

  • Pulmonary embolism

  • Avascular necrosis

  • Diabetic retinopathy

  • Thalassemia

  • Anemia

  • Stroke

Biomarkers

  • Secreted And Transmembrane 1

  • White Blood Cell

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved